Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells

Molecular Cancer Therapeutics

Volumn 1, Issue 14, 2002, Pages 1273-1281

  Grimshaw, Matthew J ^a   Naylor, Stuart ^b   Balkwill, Frances R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; DNA BINDING PROTEIN; ENDOTHELIN 2; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NUCLEAR PROTEIN; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ANOXIA; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; FEMALE; HUMAN; METABOLISM; NECROSIS; NORTHERN BLOTTING; OVARY TUMOR; PATHOLOGY; TIME; UPREGULATION;

ANOXIA; ANTIHYPERTENSIVE AGENTS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL SURVIVAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-2; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NECROSIS; NUCLEAR PROTEINS; OLIGOPEPTIDES; OVARIAN NEOPLASMS; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0038380366     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Battistini, B., Chailler, P., D'Orleans-Juste, P., Briere, N., and Sirois, P. Growth regulatory properties of endothelins. Peptides, 14: 385-399, 1993.
2. Kedzierski, R. M., and Yanagisawa, M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol., 41: 851-876, 2001. (Pubitemid 32385909)
3. Bagnato, A., Salani, D., Di Castro, V., Wu-Wong, J. R., Tecce, R., Nicotra, M. R., Venuti, A., and Natali, P. G. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res., 59: 720-727, 1999. (Pubitemid 29076073)
4. Gershon, M. D. Endothelin and the development of the enteric nervous system. Clin. Exp. Pharmacol. Physiol., 26: 985-988, 1999. (Pubitemid 30004322)
5. Sampaio, A. L., Rae, G. A., and Henriques, M. M. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J. Leukocyte Biol., 67: 189-195, 2000.
6. Salani, D., Taraboletti, G., Rosano, L., Di Castro, V., Borsotti, P., Giavazzi, R., and Bagnato, A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol., 157: 1703-1711, 2000.
7. Pollock, D. M., Keith, T. L., and Highsmith, R. F. Endothelin receptors and calcium signaling. FASEB J., 9: 1196-1204, 1995.
8. Natarajan, S., Hunt, J. T., Festin, S., Serafino, R., Zhang, R., and Moreland, S. Endothelin analogs which distinguish vasoconstrictor and vasodilator ETB receptors. Life Sci., 56: 1251-1256, 1995.
9. Alanen, K., Deng, D. X., and Chakrabarti, S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology, 36: 161-167, 2000. (Pubitemid 30113979)
10. Nelson, J. B., and Carducci, M. A. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. BJU Int., 85 (Suppl. 2): 45-48, 2000. (Pubitemid 30189442)
11. Ahmed, S. I., Thompson, J., Coulson, J. M., and Woll, P. J. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol., 22: 422-431, 2000. (Pubitemid 30343341)
12. Patel, K. V., Sheth, H. G., and Schrey, M. P. Stimulation or endothelin-1 secretion by human breast cancer cells through protein kinase A activation: a possible novel paracrine loop involving breast fibroblast-derived prostaglandin E2. Mol. Cell. Endocrinol., 126: 143-151, 1997. (Pubitemid 27121052)
13. Moraitis, S., Miller, W. R., Smyth, J. F., and Langdon, S. P. Paracrine regulation of ovarian cancer by endothelin. Eur. J. Cancer, 35: 1381-1387, 1999. (Pubitemid 29397440)
14. Lahav, R., Heffner, G., and Patterson, P. H. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 96: 11496-11500, 1999. (Pubitemid 29487409)
15. Asham, E., Shankar, A., Loizidou, M., Fredericks, S., Miller, K., Boulos, P. B., Burnstock, G., and Taylor, I. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br. J. Cancer, 85: 1759-1763, 2001. (Pubitemid 34081524)
16. Dachs, G. U., and Tozer, G. M. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur. J. Cancer, 36: 1649-1660, 2000. (Pubitemid 30616369)
17. Faller, D. V. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol., 26: 74-84, 1999. (Pubitemid 29051349)
18. Wiebke, J. L., Montrose-Rafizadeh, C., Zeitlin, P. L., and Guggino, W. B. Effect of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells. Biochim. Biophys. Acta, 1134: 105-111, 1992.
19. Shibaguchi, H., Himeno, A., Shigematsu, K., Kataoka, Y., and Niwa, M. Transient hypoxia/hypoglycemia up-regulates endothelin B receptors in cultured rat astrocytes. Glia, 31: 91-94, 2000. (Pubitemid 30410877)
20. Koong, A. C., Denko, N. C., Hudson, K. M., Schindler, C., Swiersz, L., Koch, C., Evans, S., Ibrahim, H., Le, Q. T., Terris, D. J., and Giaccia, A. J. Candidate genes for the hypoxic tumor phenotype. Cancer Res., 60: 883-887, 2000. (Pubitemid 30129520)
21. Bell, K. M., and Chaplin, D. J. The effect of oxygen and carbon dioxide on tumor cell endothelin-1 production. J. Cardiovasc. Pharmacol., 31 (Suppl. 1): S537-S540, 1998. (Pubitemid 128710005)
22. Runkel, S., Wischnik, A., Teubner, J., Kaven, E., Gaa, J., and Melchert, F. Oxygenation of mammary tumors as evaluated by ultrasound-guided computerized-pO2-histography. Adv. Exp. Med. Biol., 345: 451-458, 1994. (Pubitemid 24145784)
23. Dias, S., Boyd, R., and Balkwill, F. IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int. J. Cancer, 78: 361-365, 1998. (Pubitemid 28445375)
24. Dias, S., Thomas, H., and Balkwill, F. Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model. Int. J. Cancer, 75: 151-157, 1998. (Pubitemid 28113991)
25. Ihara, M., Ishikawa, K., Fukuroda, T., Saeki, T., Funabashi, K., Fukami, T., Suda, H., and Yano, M. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J. Cardiovasc. Pharmacol., 20: S11-S14, 1992. (Pubitemid 23014096)
26. Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., and Yano, M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci., 50: 247-255, 1992.
27. Ishikawa, K., Fukami, T., Nagase, T., Fujita, K., Hayama, T., Niiyama, K., Mase, T., Ihara, M., and Yano, M. Cyclic pentapeptide endothelin antagonists with high ETA selectivity. Potency- and solubility-enhancing modifications. J. Med. Chem., 35: 2139-2142, 1992.
28. Ishikawa, K., Ihara, M., Noguchi, K., Mase, T., Mino, N., Saeki, T., Fukuroda, T., Fukami, T., Ozaki, S., Nagase, T., et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA, 91: 4892-4896, 1994. (Pubitemid 24177756)
29. Turner, L., Scotton, C., Negus, R., and Balkwill, F. Hypoxia inhibits macrophage migration. Eur. J. Immunol., 29: 2280-2287, 1999. (Pubitemid 29313103)
30. Wang, G. L., and Semenza, G. L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood, 82: 3610-3615, 1993. (Pubitemid 24006041)
31. Gleadle, J. M., Ebert, B. L., and Ratcliffe, P. J. Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing. Eur. J. Biochem., 234: 92-99, 1995.
32. Onda, H., Ohkubo, S., Kosaka, T., Yasuhara, T., Ogi, K., Hosoya, M., Matsumoto, H., Suzuki, N., Kitada, C., Ishibashi, Y., et al. Expression of endothelin-2 (ET-2) gene in a human renal adenocarcinoma cell line: purification and cDNA cloning of ET-2. J. Cardiovasc. Pharmacol., 17 (Suppl. 7): S39-S43, 1991.
33. Dewhirst, M. W., Kimura, H., Rehmus, S. W., Braun, R. D., Papahadjopoulos, D., Hong, K., and Secomb, T. W. Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer Suppl., 27: S247-S251, 1996. (Pubitemid 26237971)
34. Freitas, I., Pontiggia, P., Barni, S., Bertone, V., Parente, M., Novarina, A., Roveta, G., Gerzeli, G., and Stoward, P. Histochemical probes for the detection of hypoxic tumour cells. Anticancer Res., 10: 613-622, 1990. (Pubitemid 20237807)
35. Claus, E. B., Chu, P., Howe, C. L., Davison, T. L., Stern, D. F., Carter, D., and DiGiovanna, M. P. Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors. Exp. Mol. Pathol., 70: 303-316, 2001. (Pubitemid 32607203)
36. Minchenko, A., and Caro, J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol. Cell. Biochem., 208: 53-62, 2000. (Pubitemid 30451455)
37. Ho, M. C., Lo, A. C., Kurihara, H., Yu, A. C., Chung, S. S., and Chung, S. K. Endothelin-1 protects astrocytes from hypoxic/ischemic injury. FASEB J., 15: 618-626, 2001. (Pubitemid 32245980)
38. Lee, V. Y., McClintock, D. S., Santore, M. T., Budinger, G. R., and Chandel, N. S. Hypoxia sensitizes cells to nitric oxide-induced apoptosis. J. Biol. Chem., 277: 16067-16074, 2002. (Pubitemid 34967891)
39. Mogi, M., Fukuo, K., Yang, J., Suhara, T., and Ogihara, T. Hypoxia stimulates release of the soluble form of Fas ligand that inhibits endothelial cell apoptosis. Lab. Investig., 81: 177-184, 2001. (Pubitemid 32176381)
40. Lin, Z., Weinberg, J. M., Malhotra, R., Merritt, S. E., Holzman, L. B., and Brosius, F. C., III. GLUT-1 reduces hypoxia-induced apoptosis and JNK pathway activation. Am. J. Physiol. Endocrinol. Metab., 278: E958-E966, 2000. (Pubitemid 30366415)
41. Brune, B., von Knethen, A., and Sandau, K. B. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol., 351: 261-272, 1998. (Pubitemid 28321461)
42. Kondo, A., Safaei, R., Mishima, M., Niedner, H., Lin, X., and Howell, S. B. Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Res., 61: 7603-7607, 2001. (Pubitemid 32995054)
43. Bernstein, C., Bernstein, H., Payne, C. M., and Garewal, H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res., 511: 145-178, 2002. (Pubitemid 34621252)
44. Bellacosa, A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ., 8: 1076-1092, 2001. (Pubitemid 33061825)
45. Ruetten, H., and Thiemermann, C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J. Physiol. Pharmacol., 48: 675-688, 1997. (Pubitemid 28055595)
46. Grimshaw, M. J., Wilson, J. L., and Balkwill, F. R. Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur. J. Immunol., 32: 2393-2400, 2002.